NCI Launches Formulary to Speed Availability of Investigational Cancer Drugs
By Michael Mezher -
Published 11 January 2017
The National Cancer Institute (NCI) on Wednesday launched a new effort under the cancer "Moonshot" initiative to speed access to approved and investigational drugs for use in preclinical and clinical cancer studies.
Categories: News, US, Biologics and biotechnology, Clinical, Drugs, Preclinical
Tags: National Cancer Institute, NCI, NCI Formulary, Oncology